Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2021. Start Trial.
Date Value
October 14, 2026 0.2068
October 13, 2026 0.2128
October 12, 2026 0.2336
October 09, 2026 0.2337
October 08, 2026 0.2241
October 07, 2026 0.2719
October 06, 2026 0.2705
October 05, 2026 0.29
October 02, 2026 0.3147
October 01, 2026 0.3118
September 30, 2026 0.3089
September 29, 2026 0.3118
September 28, 2026 0.3339
September 25, 2026 0.3339
September 24, 2026 0.3427
September 23, 2026 0.3575
September 22, 2026 0.3484
September 21, 2026 0.3247
September 18, 2026 0.3063
September 17, 2026 0.3275
September 16, 2026 0.3251
September 15, 2026 0.3155
September 14, 2026 0.3008
September 11, 2026 0.3146
September 10, 2026 0.3122
Date Value
September 09, 2026 0.3242
September 08, 2026 0.3386
September 04, 2026 0.3845
September 03, 2026 0.3642
September 02, 2026 0.3743
September 01, 2026 0.6543
August 31, 2026 0.7166
August 28, 2026 0.74
August 27, 2026 0.7367
August 26, 2026 0.7634
August 25, 2026 0.7794
August 24, 2026 0.7849
August 21, 2026 0.7655
August 20, 2026 0.7623
August 19, 2026 0.7365
August 18, 2026 0.8099
August 17, 2026 0.7694
August 14, 2026 0.7648
August 13, 2026 0.7581
August 12, 2026 0.7591
August 11, 2026 0.7628
August 10, 2026 0.7532
August 07, 2026 0.7819
August 06, 2026 0.7495
August 05, 2026 0.766

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Agenus, Inc. --
Amgen, Inc. 20.07
Anika Therapeutics, Inc. 2.019
BioCryst Pharmaceuticals, Inc. --
Imunon, Inc. 1.170

Price to Book Value Related Metrics

PS Ratio 4.342
Price 0.2377
Earnings Yield -381.2%
Market Cap 16.11M